http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9eef7017af7ced36f1c2151e5afa3bb
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Waring |
| name | Michael J. Waring Michael J Waring |
| given-name | Michael J. Michael J |
| organization-name | Cancer Research UK Gene Targeted Drug Design Research Group, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, U.K., Spirogen Ltd, 2 Royal College Street, London NW1 0NH, U.K., Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K., Cancer Research UK Drug-DNA Interactions Research Group, Department of Oncology, Royal Free and University... School of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, U.K., and AstraZeneca Ltd., Alderley Park, Cheshire, SK10 4TG, U.K. Laboratoire de Biophysique, Muséum National d’Histoire Naturelle, INSERM U201, CNRS URA481, 43 rue Cuvier, 75231 Paris Cedex 05, France, and Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, U.K. Department of Pharmacology, University of Cambridge Medical School, Hills Road, Cambridge CB2 2QD, U.K. Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, England, Laboratoire de Biophysique, Muséum National d'Histoire Naturelle, INSERM U201-CNRS UA481, 43 rue Cuvier, 75005 Paris, France, Institut de Recherches sur le Cancer, INSERM U124, Place de Verdun, 59045 Lille Cedex, France, and Laboratoire de Synthèse organique, Institut Curie-Recherche, CNRS URA 1387, Bâtiment 110-112, 15 rue G. Clemenceau, 91405 Orsay, France Laboratoire de Pharmacologie Antitumorale Moléculaire du Centre Oscar Lambret et INSERM U-124, Place de Verdun, 59045 Lille, France, Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, U.K., and Department of Biochemistry, University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216-4505 Laboratoire de Chimie Macromoléculaire et Chimie Physique, Université de Liège, Sart-Tilman (B6), Liège 4000, Belgium, Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, U.K., and INSERM U124, Institut de Recherches sur le Cancer, Place de Verdun, 59045 Lille Cedex, France Department of Pharmacology, University of Cambridge Oncology Innovative Medicines, ‡Drug Safety and Metabolism, §Global Medicines Development, and ∥Discovery Sciences, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K. Department of Chemistry, Tunghai Christian University, Taichung, Taiwan 407, Republic of China, and Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QJ, England, U.K Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, U.K., Institut de Recherches sur le Cancer, INSERM U124, Place de Verdun, 59045 Lille Cedex, France, and Ciba-Geigy Ltd., Pharmaceutical Division, Basel 4002, Switzerland 2AstraZeneca, Macclesfield, Cheshire, UK. Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, United Kingdom; Institut National de la Santé et de la Recherche Médicale, Unité 124, Place de Verdun, 59045 Lille, France; and Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, United Kingdom Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom, Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom, Centre for Molecular Architecture, Central Queensland University, Rockhampton, Australia 4702, School of Biological and Chemical Science, Deakin University, Waurn Ponds, Victoria, Australia 3217, Adelaide Graduate Centre, University of Adelaide, 10 Pulteney St., Adelaide, South Australia 5000 Dyson Perrins Laboratory, South Parks Road, Oxford, OX1 3QY, UK, Department of Chemistry, University of Manchester, Oxford Road, Manchester, M13 9PL, UK, AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK, and GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK Department of Pharmacology; University of Cambridge; , UK AstraZeneca; Cambridge; UK Department of Medical Biochemistry and Genetics, The Panum Institute, Blegdamsvej 3c, DK-2200 Copenhagen N, Denmark, Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret and INSERM U524, IRCL, Place de Verdun, 59045 Lille, France, and Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, U.K. AstraZeneca; Macclesfield, UK Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K., INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France, Département de Pharmacochimie Moléculaire et Structurale, INSERM U266-CNRS UMR 8600, Faculté de Pharmacie, 4, Avenue de l'Observatoire, 75270 Paris, France, and Department of Chemistry, Box 90346, Duke University, Durham, North Carolina 27708-0346 Department of Biochemistry, Division of Infectious Diseases, and Center for AIDS Research, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4984, Division of Virology, Glaxo-Wellcome Inc., Research Triangle Park, North Carolina 27709, and Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QJ, U.K. Jesus College Cambridge CB5 8BL UK IMED Oncology, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K. Department of Chemistry, Hunter College, City University of New York, New York 10021, and Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, U.K. Northern Institute for Cancer Research and Chemistry, School of Natural & Environmental Sciences, Bedson Building, Newcastle University, Newcastle upon Tyne, UK Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, England Oncology and Discovery Sciences, IMED Biotech Unit, AstraZeneca, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K. Cancer Research UK Newcastle Drug Discovery Unit; Chemistry; School of Natural and Environmental Sciences; Newcastle University; Newcastle upon Tyne AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.; Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle upon Tyne NE1 7RU, U.K. Department of Chemistry, Tunghai Christian University, Taichung, Taiwan 407, ROC, Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, U.K., and Shaw College, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom, Cancer Research UK Drug−DNA Interactions Research Group, Department of Oncology, Royal Free and University College Medical School, UCL, 91 Riding House Street, London W1W 7BS, United Kingdom, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom, and Cancer Research UK Gene Targeted Drug Design Research Group, The School of Pharmacy... AstraZeneca R&D, Alderley Park, Macclesfield, SK10 4TG, UK |
Incoming Links
Total number of triples: 179.